Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
Ocugen (NASDAQ: OCGN) will hold a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 5, 2025 to discuss third quarter 2025 financial results and provide a business update. The company will issue a pre-market earnings announcement the same day.
Dial-in numbers: U.S. (800) 715-9871, international (646) 307-1963; Conference ID: 3029428. The webcast is available in the events section of the Ocugen investor site. A replay and archived webcast will be available for approximately 45 days after the event.
Ocugen (NASDAQ: OCGN) terrà una conference call e una webcast in diretta alle 8:30 a.m. ET mercoledì 5 novembre 2025 per discutere i risultati finanziari del terzo trimestre 2025 e fornire un aggiornamento sull'andamento aziendale. L'azienda emetterà un annuncio sui risultati pre-mercato nello stesso giorno.
Numeri per la connessione: USA (800) 715-9871, internazionale (646) 307-1963; ID conferenza: 3029428. Il webcast è disponibile nella sezione eventi del sito investitori di Ocugen. Una replica e un webcast archiviato saranno disponibili per circa 45 giorni dopo l'evento.
Ocugen (NASDAQ: OCGN) realizará una llamada de conferencia y una transmisión en vivo a las 8:30 a.m. ET el miércoles 5 de noviembre de 2025 para discutir los resultados financieros del tercer trimestre de 2025 y proporcionar una actualización comercial. La empresa emitirá un anuncio de resultados previo a la apertura ese mismo día.
Números de acceso: EE. UU. (800) 715-9871, internacional (646) 307-1963; ID de conferencia: 3029428. La transmisión en vivo está disponible en la sección Eventos del sitio de inversionistas de Ocugen. Una reproducción y una transmisión grabada estarán disponibles por aproximadamente 45 días después del evento.
Ocugen (NASDAQ: OCGN)은 2025년 11월 5일 수요일 동부 표준시 오전 8시 30분에 컨퍼런스 콜과 라이브 웨비캐스트를 개최하여 2025년 3분기 재무 실적을 논의하고 비즈니스 업데이트를 제공합니다. 같은 날 프리마켓 실적 발표를 발표합니다.
다이얼인 번호: 미국(800) 715-9871, 국제적으로 (646) 307-1963; 회의 ID: 3029428. 웨비캐스트는 Ocugen 투자자 사이트의 events 섹션에서 이용 가능합니다. 이벤트 종료 후 약 45일 동안 재생 및 보관 웨비캐스트를 이용할 수 있습니다.
Ocugen (NASDAQ: OCGN) organisera une conférence téléphonique et une diffusion en direct à 8 h 30 (HE) le mercredi 5 novembre 2025 pour discuter des résultats financiers du troisième trimestre 2025 et fournir une mise à jour sur les activités. L'entreprise publiera le même jour un communiqué sur les résultats avant l'ouverture du marché.
Numéros de conférence : États-Unis : (800) 715-9871, international (646) 307-1963; ID de conférence : 3029428. La diffusion en direct est disponible dans la rubrique events du site investisseurs Ocugen. Une rediffusion et une diffusion en ligne archivées seront disponibles pendant environ 45 jours après l'événement.
Ocugen (NASDAQ: OCGN) wird eine Telefonkonferenz und einen Live-Webcast abhalten am 8:30 Uhr ET am Mittwoch, dem 5. November 2025, um die Finanzergebnisse des dritten Quartals 2025 zu besprechen und ein Geschäftsupdate zu geben. Das Unternehmen wird am selben Tag eine vorbörsliche Gewinnankündigung veröffentlichen.
Wählnummern: USA (800) 715-9871, international (646) 307-1963; Konferenz-ID: 3029428. Der Webcast ist im Veranstaltungen-Bereich der Ocugen-Investorenseite verfügbar. Eine Wiedergabe und archivierte Webcasts stehen ca. 45 Tage nach der Veranstaltung zur Verfügung.
Ocugen (NASDAQ: OCGN) ستعقد مكالمة مؤتمر وبثاً مباشراً عبر الويب في 8:30 صباحاً بالتوقيت الشرقي القياسي يوم الأربعاء 5 نوفمبر 2025 لمناقشة نتائج الربع الثالث من 2025 وتقديم تحديث عن الأعمال. ستصدر الشركة إعلاناً عن الأرباح قبل فتح السوق في اليوم نفسه.
أرقام الاتصال: الولايات المتحدة (800) 715-9871، دولياً (646) 307-1963; معرّف المؤتمر: 3029428. يمكن الوصول إلى البث عبر الويب في قسم الأحداث في موقع Ocugen للمستثمرين. ستتوفر إعادة تشغيل وبث ويب محفوظ لمدة تقارب 45 يوماً بعد الحدث.
Ocugen (NASDAQ: OCGN) 将于 2025 年 11 月 5 日星期三，美国东部时间上午 8:30 召开电话会议并进行现场网络广播，讨论 2025 年第三季度财务业绩并提供业务更新。公司当天将发布一份盘前盈利公告。
拨入号码：美国（800）715-9871，国际 （646）307-1963；会议 ID：3029428。网络广播可在 Ocugen 投资者网站的 活动 部分查看。事件结束后，约 45 天 内将提供回放和存档的网络广播。
- None.
- None.
MALVERN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s third quarter 2025 financial results and provide a business update at 8:30 a.m. ET on Wednesday, November 5, 2025.
Ocugen will issue a pre-market earnings announcement on the same day. Attendees are invited to participate on the call using the following details:
Dial-in Numbers: (800) 715-9871 for U.S. callers and (646) 307-1963 for international callers
Conference ID: 3029428
Webcast: Available on the events section of the Ocugen investor site
A replay of the call and archived webcast will be available for approximately 45 days following the event on the Ocugen investor site.
About Ocugen, Inc.
Ocugen, Inc. is a pioneering biotechnology leader in gene therapies for blindness diseases. Our breakthrough modifier gene therapy platform has the potential to address significant unmet medical need for large patient populations through our gene-agnostic approach. Unlike traditional gene therapies and gene editing, Ocugen’s modifier gene therapies address the entire disease—complex diseases that are potentially caused by imbalances in multiple gene networks. Currently we have programs in development for inherited retinal diseases and blindness diseases affecting millions across the globe, including retinitis pigmentosa, Stargardt disease, and geographic atrophy—late stage dry age-related macular degeneration. Discover more at www.ocugen.com and follow us on X and LinkedIn.
Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.
Contact:
Tiffany Hamilton
AVP, Head of Communications
Tiffany.Hamilton@ocugen.com
FAQ
When will Ocugen (OCGN) present its Q3 2025 results and webcast?
How can investors join the Ocugen (OCGN) Q3 2025 earnings call?
Where is the Ocugen (OCGN) webcast for the November 5, 2025 earnings call?
Will Ocugen (OCGN) release earnings before the market opens on November 5, 2025?
How long will the replay of the Ocugen (OCGN) Q3 2025 webcast remain available?
